Oxford University & drugmaker AstraZeneca has developed an experimental coronavirus vaccine. This experimental vaccine shows a protective immune response in its early trials. According to researchers, it induced a strong antibody and T cell immune response.
The trials have also been expanded to other countries because of low levels of coronavirus in UK. Phase III trials will involve people from other countries like US, South Africa and Brazil. Many countries including Germany, France, Italy, & U.S. have already signed deals for the vaccine.
UK coronavirus vaccine prompts immune response in early test. Read more here:
Thank you for watching our video!
You can subscribe to our channel here:
Visit for the latest updates, analysis, opinions, and more.
The Hindu is committed to keeping you up-to-date with information on the developments in India and the world. We promise to deliver quality journalism that stays away from vested interest and political propaganda. You can support us by subscribing to our digital offerings here:
Follow us:
Twitter:
Instagram:
